Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04830592 |
| Title | A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck (MOAT) |
| Acronym | MOAT |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | PsiOxus Therapeutics Ltd |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cardiff & Vale University LHB | Cardiff | United Kingdom | Details | |||
| The Clatterbridge Cancer Centre | Liverpool | United Kingdom | Details | |||
| The Royal Marsden Hospital | London | United Kingdom | Details | |||
| University Hospital Southampton NHS Foundation Trust | Southampton | SO16 6YD | United Kingdom | Details |